SAC Capital Raises Stake in Ariad Pharmaceuticals, Inc. (ARIA) to 4.9%
Tweet
Share
E-mail
Get Alerts ARIA Hot Sheet
Join SI Premium – FREE
In a 13G filing on Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA), Steven Cohen's hedge fund SAC Capital disclosed a 4.96%, or 7,876,700 share, stake in the company. This is up 208.73% from the 2,551,325 shares held at the end of the latest quarter ending December 31, 2011.
While the fund sharply increased its stake, December 31, 2011 it has recently ceased to be the beneficial owner of more than five percent of the class of securities.
For more notable holders of Ariad Pharmaceuticals, Inc. stock click here. For more information on SAC Capital click here.
While the fund sharply increased its stake, December 31, 2011 it has recently ceased to be the beneficial owner of more than five percent of the class of securities.
For more notable holders of Ariad Pharmaceuticals, Inc. stock click here. For more information on SAC Capital click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Robo.ai names Hao Wang of Changer.ae to its board of directors
- Interactive Brokers adds access to the Bucharest Stock Exchange
- Interactive Brokers adds SafetyPay funding for Latin America clients
Create E-mail Alert Related Categories
13Gs, Hedge FundsRelated Entities
SAC Capital, Steven A. Cohen, Hedge Funds, 13GSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
